Analysis of ID2 expression in a subset of MLL-rearranged AML patient cells indicated that MLL patients (35 patients) with high levels of ID2 expression had a significantly better overall and event free survival than patients with low levels of ID2 (122). The gene discussed is ID2; the disease is acute myeloid leukemia.